Science ❯ Medical Research ❯ Clinical Trials

Drug Development

FDA Approvals Autism Research NRTIs and Alzheimer's Regulatory T Cells Health Innovations Neurodevelopmental Disorders HIV Research Covid-19 Treatments Health Outcomes Innovative Therapies Historical Context Patient Care Immunotherapy Drugs Efficacy Studies Oral Selective Oestrogen Receptor Degraders Larazotide EGFR Mutations Schizophrenia Treatments Oncology Monoclonal Antibodies

Tufts Chemists Unveil Four-Receptor Obesity Drug to Challenge Bariatric Surgery

The novel therapy’s four-receptor approach promises to mirror surgery outcomes with improved tolerability.

Blog Jobs Terms of Service Privacy Policy Cookies Help Partners About Us Copyright © 2026 Mina Labs, Inc.

We value your privacy

We and our partners use cookies and similar technologies to understand how you use our site and to show you personalized advertisements on other platforms. By clicking "Accept All," you consent to these technologies for advertising, analytics and retargeting. Click "Decline All" to opt out of non-essential cookies. You can learn more in our Privacy Policy.